News

This spring, science and research take center stage at the Texas Science Festival. Happening Feb. 21 through March 4, the event is open to all and offers something for everyone—with options to join in or out of Texas. Participants of all ages will engage with, understand and be invigorated by scientific discovery at this year's event, themed around "Impact and Ideas to Transform Lives."

Just as humans cannot breathe underwater, the tiny pores of plants can't exchange air underwater.

Jason McLellan, a structural biologist at The University of Texas at Austin, is being honored today with the announcement of two highly prestigious awards—the National Academy of Sciences (NAS) Award in Molecular Biology and the Norman Hackerman Award in Chemical Research from the Welch Foundation.

In a first for the genetic toolset known as CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria, capable of degrading single-stranded RNA, single-stranded DNA and double-stranded DNA. With its abilities to target so many types of genetic material, the discovery holds potential for the development of new inexpensive and highly sensitive at-home diagnostic tests for a wide range of infectious diseases, including COVID-19, influenza, Ebola and Zika, according to the authors of a new study in the journal Nature.

This past spring, the College of Natural Sciences invited our University of Texas at Austin faculty, staff and students to send in the top images from their research for our Visualizing Science competition. The images they produced nourish both the mind and the soul, offering not only food for thought but a feast for the eyes as well.

Human metapneumovirus (hMPV), a virus that infects the upper and lower respiratory systems—leading to bronchitis and pneumonia in some patients—could soon meet its medical match. A scientific team in Texas, in collaboration with biotech companies, has made recent breakthroughs in understanding the virus, and their efforts could lead to everything from the first-ever vaccines against hMPV to new, highly effective therapeutics.

Over the last two decades, John Wallingford has taught developmental biology short courses to students at two of the country's most highly prestigious and competitive biological research institutions: the Marine Biological Laboratory in Woods Hole, Massachusetts, and the Cold Spring Harbor Laboratory in New York. But not all biology students have access to these transformative experiences.

​For more affordable, sustainable drug options than we have today, the medication we take to treat high blood pressure, pain or memory loss may one day come from engineered bacteria, cultured in a vat like yogurt. And thanks to a new bacterial tool developed by scientists at The University of Texas at Austin, the process of improving drug manufacturing in bacterial cells may be coming sooner than we thought.